Notes
The ‘safeguard clause’ states that any public authority should take account of the lowest price on the market in purchasing goods, as otherwise it may be sued by the Italian Audit Office for waste of public funds.
References
Schiffman M, Castle PE, Jeronimo J, et al. Human papillomavirus and cervical cancer. Lancet 2007 Sep 8; 370 (9590): 890–907
World Health Organization. Preparing for the introduction of HPV vaccine in the WHO European region: strategy paper. Copenhagen: WHO, 2008
World Health Organization, International Agency for Research on Cancer. IARC handbooks of cancer prevention. Vol. 10: cervix cancer screening. Lyon: IARC Press, 2005
Garland SM, Hernandez-Avila M, Wheeler CM, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007 May 10; 356 (19): 1928–43
Newal AT, Beutels P, Wood JG, et al. Cost-effectiveness analyses of human papillomavirus vaccination. Lancet Infect Dis 2007 Apr; 7 (4): 289–96
Arie S. Global HPV vaccination. BMJ 2011; 342: d1042
Dorleans F, Giambi C, Dematte L, et al. The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey. Euro Surveill 2010 Nov 25; 15 (47). pii: 19730
France G, Taroni F. The evolution of health-policy making in Italy. J Health Polit Policy Law 2005 Feb-Apr; 30 (1-2): 169–87
Decree of the President of the Council of Ministers: definition of essential levels of care, 2001 Nov 29 [in Italian]. Gazzetta Ufficiale 2002 Feb 8. Supplemento ordinario no. 33
Garattini L, Padula A, Casadei G. Management of vaccinations in Italy: a national survey after healthcare regionalization. J Med Econ. Epub 2011 Jul 7
Del Bufalo P. ELC: (school) reports to regions [in Italian]. Sole 24 Ore Sanità 2011 May 17-23; 9
Osservatorio Nazionale Screening, Centro nationale per la prevenzione e il Controllo delle Malattie, Conferenza dei presidenti delle regioni e delle province autonome. The National Centre for Screening Monitoring: eighth report, 2009 [in Italian; online]. Available from URL: http://www.studio-sesto.com/ons/images/stories/8_Rapporto_ONS.pdf [Accessed 2011 Jul 8]
Anttila A, von Karsa L, Aasmaa A, et al. Cervical cancer screening policies and coverage in Europe. Eur J Cancer. 2009 Oct; 45 (15): 2649–58
Istituto Superiore di Sanità. Stato di avanzamento della campagna vaccinale per l’HPV: dati di copertura vaccinale al 31/12/2010 e aggiornamento delle decisioni in merito alle strategie vaccinali [online]. Available from URL: http://www.epicentro.iss.it/focus/hpv/pdf/HPV-31-12-2010.pdf [Accessed 2011 Jul 8]
Conferenza permanente per i rapporti tra lo Stato, le Regioni e le Province autonome di Trento e di Bolzano. Strategia per l’offerta attiva del vaccino contro l’infezione da HPV in Italia [online]. Available from URL: http://www.statoregioni.it/Documenti/DOC_016696_264%20csr.pdf [Accessed 2011 Jul 8]
Codice dei contratti pubblici relativi a lavori, servizi e forniture in attuazione delle direttive 2004/17/CE e 2004/18/CE. Gazzetta Ufficiale 2006 May 2; 100. Supplemento Ordinario n. 107 [online]. Available from URL: http://www.camera.it/parlam/leggi/deleghe/testi/06163dl.htm [Accessed 2011 Nov 4]
Italian National Institute of Statistics. Bilancio demografico nazionale [online]. Available from URL: http://www.istat.it/it/archivio/1359 [Accessed 2011 Jul 8]
Garattini L, Curto A, Padula A, et al. Indagine sulla gestione regionale della vaccinazione HPV. Quad Farmacoeconomia 2011 May; 15: 15–25
Ministero della Salute. Programmazione sanitaria e LEA [online]. Available from URL: http://www.salute.gov.it/programmazioneSanitariaELea/archivioDocumentiProgrammazioneSanitariaELea.jsp?lingua=italiano&menu=documenti [Accessed 2011 May 3]
Merck. Pipeline, 2010 May 11 [media release; online]. Available from URL: http://www.merck.com/newsroom/news-releasearchive/corporate/2010_0511.html [Accessed 2011 Jul 4]
Acknowledgements
No sources of funding were used to prepare this article. The authors have no conflicts of interest that are directly relevant to the content of this article. The opinions expressed in this paper are those of the authors.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Garattini, L., van de Vooren, K. & Curto, A. Pricing Human Papillomavirus Vaccines. PharmacoEconomics 30, 213–217 (2012). https://doi.org/10.2165/11596560-000000000-00000
Published:
Issue Date:
DOI: https://doi.org/10.2165/11596560-000000000-00000